Skip to main content

Exenatide Audit IDF Montreal 2009 - Poster

Factors accounting for variability in weight and HbA1c response to exenatide in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit

R.E.J. Ryder1 , C. Walton2 , P.H. Winocour3 , ABCD nationwide exenatide audit contributors4

1City Hospital, Birmingham, United Kingdom

2Hull Royal Infirmary, Hull, United Kingdom

3Queen Elizabeth II Hospital, Welwyn Garden City

4numerous other hospitals and diabetes centres, United Kingdom

EASD Stockholm 2010b - Abstract

Safety and efficacy of using exenatide in combination with insulin in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit

B. Jose1, R.E.J. Ryder1, K.Y. Thong1, S. Thozhukat2, W. Shafiq2, ABCD nationwide exenatide audit contributors

1City Hospital, Birmingham, UK

2Hull Royal Infirmary, Hull, UK

ABCD Spring Meeting, Edinburgh, 2014, abstract 1 - Abstract

NICE guidelines versus clinical practice – GLP-1 receptor agonists in type 2 diabetes: the ABCD nationwide audits

KY Thong1, P Sen Gupta2, ML Cull2, KA Adamson3, DS Dove4, SV Rowles5, S Tarpey5, C Duncan6, J Chalmers6, R Harper7, P McDonald7, U Brennan7, C Walton8, REJ Ryder2 

1School of Medicine and Pharmacology University of Western Australia, Perth, Australia

EASD Lisbon 2011b - Abstract

Factors associated with HbA1c and weight changes at 6 months in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audit

C. Walton1, R.E.J. Ryder2, M.L. Cull2, A.P. Mills2, K.Y.Thong2

1Diabetes, Hull Royal Infirmary, Hull UK

2Diabetes, City Hospital, Birmingham, UK

EASD Lisbon 2011a - Abstract

The Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits

R.E.J. Ryder1, K.Y. Thong1, M.L. Cull1, A.P. Mills1, C. Walton2, ABCD nationwide exenatide and liraglutide audit contributors;

1Diabetes, Endocrinology and Lipids Metabolism, City Hospital, Birmingham, UK

2Hull Royal Infirmary, Hull,UK